Literature DB >> 17070080

Autologous blood vessels engineered from peripheral blood sample.

T Aper1, A Schmidt, M Duchrow, H-P Bruch.   

Abstract

OBJECTIVE: Although many efforts have been made to generate small-diameter (< or =5mm) vascular grafts by means of tissue engineering, improvement in patency and functionality still remains a great challenge. It is our hypothesis that to achieve long-term functionality and patency, not only the complete lining with endothelial cells but also full biocompatibility is essential.
DESIGN: The aim was the development of a conduit from a scaffold and endothelial progenitor cells (EPC) separated from peripheral blood of a single donor.
MATERIALS AND METHODS: EPC and a fibrin preparation were separated from porcine peripheral blood. Fibrin segments were generated seeded with EPC and were perfused in a bioreactor in vitro.
RESULTS: From 100ml blood 12-15 cm long fibrin tubes were successfully generated lined with endothelial-like cells. Seeded tubes showed a remarkable elasticity and burst strength up to 90 mm mercury.
CONCLUSIONS: Stable fibrin tubes were successfully generated completely lined with an endothelium-like monolayer from fibrin and EPC, both isolated from the same volume of blood. Although their stability is not those needed for arterial grafting, our results raise the hope, that with distinct improvements in future studies functional autologous vascular grafts could be engineered from the patient's own blood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070080     DOI: 10.1016/j.ejvs.2006.08.008

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  11 in total

1.  Maturing EPCs into endothelial cells: may the force be with the EPCs: focus on "Fluid shear stress induces differentiation of circulating phenotype endothelial progenitor cells".

Authors:  Randall F Ankeny; Casey J Ankeny; Robert M Nerem; Hanjoong Jo
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-03       Impact factor: 4.249

Review 2.  Review: advances in vascular tissue engineering using protein-based biomaterials.

Authors:  Jan P Stegemann; Stephanie N Kaszuba; Shaneen L Rowe
Journal:  Tissue Eng       Date:  2007-11

Review 3.  Endothelial outgrowth cells: function and performance in vascular grafts.

Authors:  Jeremy J Glynn; Monica T Hinds
Journal:  Tissue Eng Part B Rev       Date:  2013-10-10       Impact factor: 6.389

Review 4.  Biomaterials to prevascularize engineered tissues.

Authors:  Lei Tian; Steven C George
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

Review 5.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

Review 6.  Combinatorial biomatrix/cell-based therapies for restoration of host tissue architecture and function.

Authors:  David Antonio Cantu; W John Kao
Journal:  Adv Healthc Mater       Date:  2013-07-05       Impact factor: 9.933

7.  Shear stress responses of adult blood outgrowth endothelial cells seeded on bioartificial tissue.

Authors:  Katherine A Ahmann; Sandra L Johnson; Robert P Hebbel; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2011-07-01       Impact factor: 3.845

Review 8.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

9.  Vascular Network Formation by Human Microvascular Endothelial Cells in Modular Fibrin Microtissues.

Authors:  Ramkumar Tiruvannamalai Annamalai; Ana Y Rioja; Andrew J Putnam; Jan P Stegemann
Journal:  ACS Biomater Sci Eng       Date:  2016-09-27

10.  A novel in vitro model for microvasculature reveals regulation of circumferential ECM organization by curvature.

Authors:  Sebastian F Barreto-Ortiz; Shuming Zhang; Matthew Davenport; Jamie Fradkin; Brian Ginn; Hai-Quan Mao; Sharon Gerecht
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.